Skip to main content
. 2024 Jun 24;12(6):101934. doi: 10.1016/j.jvsv.2024.101934

Table I.

Patient characteristics

GE-VLNT LTW-VLNT SI-VLNT P value
Patients 49 16 5 NA
Extremities operated 61 (74) 16 (20) 5 (6) NA
Age, years 41 ± 17 55 ± 10 58 ± 11 .003
BMI, kg/m2 26 ± 5 27 ± 5 26 ± 5 .9
Lymphedema stage (operated extremity)a .08
 I 14 (23) 1 (6) 0 (0)
 II 42 (69) 10 (63) 4 (80)
 III 5 (8) 5 (31) 1 (20)
Duration until surgery, years 11.71 ± 10.79 11 ± 9 6 ± 4 .49
Cause of lymphedema .008
 Primary 28 (57) 4 (25) 0 (0)
 Secondary 21 (43) 12 (75) 5 (100)
Affected anatomical region NA
 Lower extremity 37 (76) 16 (100) 0 (0)
 Upper extremity 10 (20) 0 (0) 5 (100)
 Lower extremity and genitals 2 (4) 0 (0) 0 (0)
Laterality of disease .33
 Unilateral 34 (69) 12 (75) 5 (100)
 Bilateral 15 (31) 4 (25) 0 (0)
Recurrent erysipelas 18 (30) 5 (31) 1 (20) .88
Concomitant diseasea
 None 29 (59) 12 (75) 3 (60) .52
 Vascular, hypertension, diabetes, coronary artery disease 9 (18) 2 (13) 0 (0) NA
 Venous disease (venous insufficiency, thrombosis, varicose veins) 3 (6) 0 (0) 0 (0) NA
 Metabolic (adipositas, thyroid, metabolic syndrome) 8 (16) 2 (13) 2 (40) NA
 Inflammatory disease 1 (2) 0 (0) 0 (0) NA
 Arthritis/osteoporosis 2 (4) 0 (0) 0 (0) NA
 Pulmonary, asthma 4 (8) 0 (0) 0 (0) NA
 Other syndromes 2 (4) 0 (0) 0 (0) NA

BMI, Body mass index; GE, gastroepiploic; LTW, lateral thoracic wall; NA, not avaiable; SI, superficial inguinal region; VLNT, vascularized lymph node transfer.

Values are mean ± standard deviation or number (%).

a

More than one value is possible for every patient or extremity operated.